Skip to main content
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
2.650
-0.070 (-2.57%)
At close: Mar 9, 2026, 4:00 PM EDT
2.370
-0.280 (-10.57%)
After-hours: Mar 9, 2026, 6:26 PM EDT

UPC Revenue

In the fiscal year ending September 30, 2025, Universe Pharmaceuticals INC had annual revenue of $17.86M, down -22.44%. Universe Pharmaceuticals INC had revenue of $8.71M in the half year ending September 30, 2025, a decrease of -37.10%.

Revenue (ttm)
$17.86M
Revenue Growth
-22.44%
P/S Ratio
0.08
Revenue / Employee
$82,679
Employees
216
Market Cap
1.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202517.86M-5.17M-22.44%
Sep 30, 202423.02M-9.28M-28.74%
Sep 30, 202332.31M-7.83M-19.52%
Sep 30, 202240.14M-7.84M-16.34%
Sep 30, 202147.98M17.28M56.27%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 37.61M
Sunshine Biopharma 37.32M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
RedHill Biopharma 9.55M
InMed Pharmaceuticals 4.51M
China Pharma Holdings 4.05M
China SXT Pharmaceuticals 1.54M
Revenue Rankings

UPC News

More News